Skip to main content
The Lotus Endometriosis Institute Logo
A beautiful landscape of lotus flowers

Clearing Up Confusion in Endometriosis Care (Part 1)

Untangling mixed messages about surgery, medications, and complementary care.

By Dr Steven Vasilev
Eye-level scene of a person aligning a clear overlay on a transit-style care map to reveal three simplified routes—surgery, medications, and complementary care—signaling clarity amid mixed messages.

Endometriosis Management: Navigating ACOG Guidelines


Management strategies for endometriosis aim primarily to alleviate pain and, when needed, support fertility, yet confusion and inconsistency in recommendations remain alarming. This article reviews and comments on key current management strategies supported by the American College of Obstetrics and Gynecologists (ACOG), referencing Bulletin #114 (2010, reaffirmed 2022) and Bulletin #760 concerning adolescents (2018, reaffirmed 2022). In the following posts, we will review other guidelines to provide a more in-depth look at these inconsistencies and what you may face as you navigate your journey with endometriosis.


Other internationally recognized bodies have also published guidelines to aid clinicians in diagnosing and treating endometriosis. Unfortunately, discrepancies between recommendations are significant, reflecting the complex nature of the disease and research limitations to date. Many patients turn to online resources and forums after seeing providers and not achieving results, only to find that information on sites dedicated to endometriosis often conflicts with what various guideline resources propose.


Surgery


Surgery is considered a cornerstone in managing pain and infertility associated with endometriosis. The timing of surgery and the type of procedure recommended vary among guidelines. ACOG guideline Bulletin #114 states that “definitive diagnosis of endometriosis only can be made by histology of lesions removed at surgery.”


Minimally invasive surgery is preferred over open surgery (laparotomy) because it is associated with less pain, shorter hospital stays, faster recovery, and better cosmetic results. Regardless of whether the approach is laparoscopic or robotically assisted, a high level of surgical skill and expertise is required. Although robotic platforms offer advanced technology, outcomes research does not clearly demonstrate superiority of one modality over another, and the surgeon’s skill likely matters more than the tools used. Robotic surgery may be particularly well suited for difficult cases with severely distorted anatomy due to advanced disease or scarring from repeat surgeries.


Excision of endometriosis is widely recommended for endometriosis-associated pain. However, the preferred technique—ablation versus excision—remains debated due to a lack of conclusive evidence. Existing studies comparing excision with ablation have notable limitations, potentially reflecting variability in surgeons’ skill and training. In other words, some studies may not have involved true excision specialists, resulting in incomplete removal and skewed outcomes. This variation in expertise is a common challenge in research on surgical procedures.


For ovarian endometriosis (endometriomas or chocolate cysts), minimally invasive excision is superior to drainage and ablation in reducing recurrence of dysmenorrhoea, dyspareunia, cyst recurrence, and the need for further surgical interventions.


When family planning is complete and conservative treatments have failed, hysterectomy with simultaneous excision of endometriotic lesions is considered a last resort. Except in cases with coexisting adenomyosis, hysterectomy is not necessarily required for pain relief. Each situation should be highly individualized.


Get Clear on Your Treatment Options

Our specialists are here to help you understand your condition and explore your treatment options.

Schedule Your Appointment

Medical Management of Endometriosis


While surgery helps many patients, medical management plays a crucial role in symptom control and fertility preservation, focusing on pain management, hormonal suppression, and birth control.


Pain management is fundamental. Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for symptomatic treatment of dysmenorrhea and acyclic pelvic pain. In its discussion of dysmenorrhea and endometriosis in adolescents, ACOG asserts—without any workup—that the majority of adolescents have primary dysmenorrhea, defined as painful menstruation in the absence of pelvic pathology, and recommends first-line therapies such as NSAIDs and birth control. This raises concerns: without definitive assessment (surgery) for endometriosis and given that imaging is insufficient for diagnosis, how is pelvic pathology excluded? Furthermore, ACOG considers symptomatic response to birth control pills and NSAIDs as confirmation of primary dysmenorrhea, though some people with endometriosis also respond symptomatically to these treatments.


Hormonal suppression using progestins, combined oral contraceptives, micronized progesterone, or Gonadotropin-releasing hormone (GnRH) analogues is a common strategy. This approach assumes estrogen is responsible for endometriosis, but it reflects an incomplete understanding of disease genesis and progression. Hormones are clearly involved, yet increasing molecular evidence indicates they are not the sole driver of endometriosis growth.


Combined oral contraceptives are often used as a first-line therapy for endometriosis-associated pain. By suppressing ovulation, they may help slow the growth of endometriotic tissue; however, they have not been proven to induce regression or resolution.


GnRH analogues are recommended as second-line options for endometriosis-associated pain and work by suppressing estrogen production, thereby theoretically reducing the growth of endometriotic tissue. In this context, ACOG states that “there is no data that support the use of preoperative medical suppressive therapy,” yet in clinical practice, many individuals are offered these medications inconsistently with respect to the consideration or timing of surgery. Additionally, ACOG’s level B evidence (second level) recommendations state: “After an appropriate pretreatment evaluation (to exclude other causes of chronic pelvic pain) and failure of initial treatment with OCs (oral contraceptives) and NSAIDS, empiric therapy with a 3-month course of a GnRH agonist is appropriate.” It can be argued that this is problematic given the lack of conclusive data supporting the use of these medications prior to surgery, and there is a significant risk of short- and potentially long-term side effects and complications.


Complementary Therapies


Complementary options such as dietary interventions, acupuncture, and electrotherapy are gaining recognition as potential adjuncts. While there is supportive evidence for several approaches, more research is needed to establish efficacy and safety. As a result, guidelines do not routinely address these modalities, often leaving patients to rely on personal trial and error.


Conclusion


Managing endometriosis typically requires a multifaceted approach, combining surgical and medical treatments that must be tailored to each patient. In recent years, research and advocacy have improved. Finding a knowledgeable, specialized surgeon and care team is of utmost importance. The majority of OBGYNs do not focus on endometriosis, have not undergone further specialized training, and generally align with ACOG guidelines, often influenced by perceived medico-legal concerns related to standard of practice. Notably, other guidelines also differ in their opinions and recommendations regarding medical management and surgery.

References

  1. Bulletins–Gynecology, A. C. o. P. (2000). ACOG practice bulletin. Medical management of endometriosis. Number 11, December 1999 (replaces Technical Bulletin Number 184, September 1993). Clinical management guidelines for obstetrician-gynecologists. _Int J Gynaecol Obstet_, _71_(2), 183-196. )80034-x DOI: 10.1016/s0020-7292(00)80034-x

  2. ACOG Committee Opinion No. 760: Dysmenorrhea and Endometriosis in the Adolescent. (2018). _Obstet Gynecol_, _132_(6), e249-e258. DOI: 10.1097/AOG.0000000000002978

Quick Answers

How much time off work do I need after endometriosis surgery?

Most people need about 2–3 weeks off work after minimally invasive endometriosis excision, especially if your job is mainly desk-based and you can ease back in. With robotic excision, patients often go home the same day or next day, start walking comfortably within about a week, and many feel ready for a gradual return to typical daily routines in that 2–3 week window.


The exact time off depends less on the incision size and more on what we need to treat during surgery—for example, ovarian endometriomas, bowel/bladder/ureter involvement, extensive scar tissue (“frozen pelvis”), or additional procedures like appendix removal or adenomyosis-related surgery. More complex, multi-organ cases can mean more fatigue, more activity restrictions, and a higher chance of needing an overnight stay, which can extend the time you’ll want to plan away from work.


In most straightforward recoveries, many patients are back to full activity by about a month. If you tell our team what you do for work (lifting, long shifts, travel, on-your-feet all day vs remote/desk), we can help you plan a realistic time-off request and a safer return-to-work ramp based on the surgical plan we’re building for you.

Read full answer

When is hysterectomy recommended for adenomyosis?

A hysterectomy is typically considered for adenomyosis when symptoms are severe and clearly uterus-driven—most often heavy bleeding (sometimes with anemia), intense cramping, pelvic pressure, and daily quality-of-life disruption—and you’re not planning future pregnancy. It’s the most definitive option because adenomyosis lives within the uterine muscle, so removing the uterus removes the source of the problem.


In practice, we usually weigh hysterectomy most strongly when conservative options haven’t brought acceptable relief, aren’t tolerated, or don’t fit your goals. The decision also depends on the pattern and extent of disease (diffuse adenomyosis versus a more focal adenomyoma that may be removable while preserving the uterus) and whether endometriosis may also be present. If endometriosis is part of the picture, it’s important to know that hysterectomy alone doesn’t treat disease outside the uterus—durable symptom relief depends on addressing all pain generators.


If you’re wondering whether you’re at the point where hysterectomy makes sense, our team can help clarify what’s most likely driving your symptoms, review imaging, and walk you through uterus-preserving versus definitive surgical paths so you can choose the option that best matches your relief and fertility priorities.

Read full answer

Is uterine artery embolization (UAE) right for adenomyosis?

Uterine artery embolization (UAE)—sometimes called adenomyosis embolization—can be a good fit when your main goal is symptom relief while preserving the uterus, especially if heavy bleeding and uterine “bulk” symptoms are a big part of your day-to-day. It’s a radiology procedure that reduces blood flow to targeted uterine tissue with the aim of shrinking or calming adenomyosis-related changes. Many patients do report meaningful improvement in quality of life after UAE, and the recovery is typically shorter than major surgery.


Whether it’s “right” depends on what you’re trying to solve (bleeding, pain, fertility, or all three) and whether adenomyosis is the primary driver of your symptoms—or if endometriosis is also part of the picture. In head-to-head research in people with MRI-confirmed, therapy-resistant adenomyosis who were eligible for hysterectomy and not trying to conceive, both UAE and hysterectomy improved quality of life at 1 year, but hysterectomy tended to have an advantage for pain relief and satisfaction. If you want the most definitive option for uterus-driven symptoms, hysterectomy is the clearest “source removal” treatment, while UAE is better viewed as a uterus-preserving option that may help substantially but isn’t guaranteed to be as durable.


If you’re weighing UAE, our team can help you clarify your diagnosis (including whether endometriosis may be contributing), review your imaging and goals, and map out a plan that matches the level of relief you need—now and long-term. Explore our adenomyosis care resources, and reach out to schedule a consultation if you want a personalized decision pathway.

Read full answer

How do I choose an adenomyosis specialist or surgeon?

Choosing an adenomyosis specialist starts with matching the team’s focus to your goal: controlling heavy bleeding and anemia, reducing pain/pressure, preserving fertility, or pursuing definitive treatment. Because adenomyosis often can’t be confirmed with absolute certainty unless the uterus is examined by a pathologist after hysterectomy, the right clinician is someone who is comfortable working with an “imaging + symptoms” diagnosis and can clearly explain how that uncertainty affects your options. You should feel that your plan is individualized—not a one-size-fits-all default to hormones, or a reflex straight to hysterectomy.


When surgery is on the table, look for a surgeon who routinely performs minimally invasive complex pelvic surgery and can describe what they do when adenomyosis overlaps with endometriosis, adhesions, fibroids, or bladder/bowel/ureter involvement. Ask how they decide between uterus-preserving strategies versus hysterectomy, how they plan to protect organs and manage bleeding risk, and what they do to reduce repeat procedures. Our team takes a coordinated approach—careful pre-op planning, meticulous minimally invasive technique when appropriate, and clear goal-based decision-making—and you can explore our approach on the site or reach out to schedule a consultation to review your symptoms, imaging, and priorities.

Read full answer

What is pelvic dissection in endometriosis surgery?

Pelvic dissection in endometriosis surgery means carefully separating and opening tissue planes in the pelvis so we can clearly see normal anatomy and remove disease safely. Endometriosis can cause inflammation and scarring that “glues” organs together (sometimes called a frozen pelvis), so dissection is often the step where we free adhesions and restore normal relationships between the uterus, ovaries, bowel, bladder, and pelvic sidewalls.


In practical terms, pelvic dissection may include identifying and protecting critical structures like the ureters, bladder, bowel, blood vessels, and pelvic nerves before excising endometriosis at its roots. This is where surgical precision matters: the goal is to fully address disease while minimizing injury to healthy tissue, especially in complex or re-operative cases. If you’re seeing this term on an op note or surgical plan, it usually reflects the complexity of the anatomy and the deliberate work needed to make excision both complete and safe—our team can walk you through exactly what was dissected and why in your specific case.

Read full answer

Reach Out

Have a question?

Lotus Endometriosis Institute provides California-based surgical evaluation and advanced excision care for patients with suspected endometriosis, adenomyosis, complex pelvic pain, and related conditions.


Many patients contact us from outside California to learn whether traveling for in-person evaluation and possible surgery may be appropriate.

Call Us

(424) 255-1340

(805) 920-0909

Fax: (805) 935-4338

Santa Monica, CA

2121 Santa Monica Blvd, Santa Monica, CA 90404

Operating Hours

8am - 5pm
Monday - Friday

Arroyo Grande, CA

154 Traffic Way, Arroyo Grande, CA 93420